×

Tesaro: Next big thing in biotech?

5:45 PM ET Mon, 13 Jan 2014

Lonnie Moulder, Tesaro CEO, discusses the drug Rolapitant, which controls the effects of chemotherapy. Moulder says it's not about market share but about accessing patients who should receive the drug.